| Eysuvis (U.S.N.L.M.) | ||
|---|---|---|
| Dosing | Shake 2 to 3 seconds. Use 1 or 2 drops qid, up to 2 weeks if needed. | |
| Chem Specs | loteprednol etabonate 0.25% | |
| Quantities | 8.3 mL (in a 10 mL bottle) | |
| Cost | 561.00 | |
| Class | Ester based "soft" steroid suspension | |
| Action | Anti-inflammatory | |
| Usage | Indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease. |
|
| Prescribe and renew prescription only after biomicroscopic exam and iop evaluation. | ||
| Contraindications | Most viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis, vaccinia, and varicella, mycobacterial and fungal disease. Hypersensitivity to any of the ingredients of this preparation and to other corticosteroids. |
|
| Pediatric use | Safety and effectiveness in pediatric patients have not been established. | |
| Pregnancy | Fetal malformations occur in rabbits with oral administration of 1.4 times the human ophthalmic dose. | |
| Fungal and bacterial overgrowth, cataract formation, globe perforation possible with long term use. | ||
| 0.01% BAK preserved. Remove contact lenses prior to instillation. Wait 15 minutes prior to reinsertion. Coated nanoparticles facilitate penetration through the mucus barrier. |
||